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Amidase Signature Family
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Abstract

Allophanate hydrolase (AH) catalyzes the hydrolysis of allophanate, an intermediate in atrazine degradation and
urea catabolism pathways, to NH3 and CO2. AH belongs to the amidase signature family, which is characterized
by a conserved block of 130 amino acids rich in Gly and Ser and a Ser-cis-Ser-Lys catalytic triad. In this study, the
first structures of AH from Granulibacter bethesdensis were determined, with and without the substrate
analogue malonate, to 2.2 and 2.8 Å, respectively. The structures confirm the identity of the catalytic triad
residues and reveal an altered dimerization interface that is not conserved in the amidase signature family. The
structures also provide insights into previously unrecognized substrate specificity determinants in AH. Two
residues, Tyr299 and Arg307, are within hydrogen bonding distance of a carboxylate moiety of malonate. Both
Tyr299 and Arg307 were mutated, and the resulting modified enzymes revealed >3 order of magnitude reductions
in both catalytic efficiency and substrate stringency. It is proposed that Tyr299 and Arg307 serve to anchor and
orient the substrate for attack by the catalytic nucleophile, Ser172. The structure further suggests the presence of
a unique C-terminal domain in AH. While this domain is conserved, it does not contribute to catalysis or to the
structural integrity of the core domain, suggesting that it may play a role in mediating transient and specific
interactions with the urea carboxylase component of urea amidolyase. Analysis of the AH active site architecture
offers new insights into common determinants of catalysis and specificity among divergent members of the
amidase signature family.
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Allophanate hydrolase (AH, EC 3.5.1.54) catalyzes the hydrolysis of allophanate to ammonia and carbon dioxide
(Scheme 1). It is a member of the amidase signature (AS) family, characterized by a highly conserved stretch of
up to 130 amino acids rich in serine and glycine.(1, 2) The AS family is currently known to include more than 200
different enzymes in organisms ranging from bacteria to plants and mammals.(3) These enzymes participate in
diverse biological activities, including the catabolism of neuromodulatory fatty acids in mammals by fatty acid
amide hydrolase,(4) formation of Gln-tRNAGln by GatCAB in a subset of bacteria,(5) formation of the plant
development regulator, indole-3-acetic acid, by nitrile hydratase,(6) and the hydrolysis of malonamate by
malonamidase in the transport of nitrogen from the bacteroid to the plant during nitrogen fixation.(7) In
addition, AS family enzymes have been implicated in a variety of industrial applications, such as the degradation
of nylon polymers(8, 9) and the amidation of synthetic peptides.(10) AS family enzymes utilize a conserved Sercis-Ser-Lys triad to catalyze amide bond hydrolysis, where the underlined serine residue serves as the catalytic
nucleophile.(11) Nucleophilic attack by serine results in a covalent tetrahedral intermediate that is stabilized by
an oxyanion hole. After ammonia had been displaced, the covalent intermediate is hydrolyzed to release the
product. Although the catalytic triad is conserved, AS family enzymes exhibit a wide variation in residues that
contribute to substrate specificity. Given the broad cross section of substrates upon which AS family enzymes
act, this family serves as an intriguing paradigm for relating molecular architecture to substrate specificity.
Scheme 1

AH was first characterized as one domain of the multifunctional fungal enzyme urea amidolyase. Urea
amidolyase is a biotin-dependent enzyme comprised of two separate enzymatic activities, urea carboxylase and
AH, that hydrolyze urea to ammonia and carbon dioxide in a two-step process. A carboxyl group is added to urea
by urea carboxylase, forming allophanate, which is subsequently hydrolyzed into ammonia and carbon dioxide
by AH. Urea amidolyase is the terminal enzyme of urea degradation and arginine catabolism.(12, 13) It is a
virulence factor in Candida albicans, an opportunistic pathogen that can evade the human immune system and
cause lethal infections in immunocompromised patients. The urea carboxylase component of Kluyveromyces
lactis urea amidolyase was recently crystallized and characterized.(14) However, the structure of the AH domain
remains undefined.
Unlike urea amidolyase enzymes in fungi, urea carboxylase and AH exist as separate subunits in bacteria.(15,
16) It is not clear whether and to what degree these subunits physically interact to affect bacterial urea
amidolyase activity. In addition, Shapir et al.(17) have determined that AH from Pseudomonas sp. strain ADP-1 is
involved in cyanuric acid metabolism and that this enzyme has no association with urea carboxylase. In this
pathway, AH serves as the terminal enzyme in s-triazine ring catabolism and serves an important role in the
biodegradation of herbicides such as atrazine. Phylogenetic analysis has revealed that AH is broadly distributed
in bacteria, where it functions in the metabolism of both cyanuric acid and urea.(18)
Here we report the first crystal structures of AH, both with and without a bound substrate analogue, malonate,
in the active site. The structure of AH from the bacterium Granulibacter bethesdensis confirms the location of
the Ser-cis-Ser-Lys catalytic triad conserved throughout the AS family. Comparison of the AH structure to those
from other AS family enzymes offers insights into substrate specificity determinants in AH. Two amino acids,
Tyr299 and Arg307, are conserved in AH and are within hydrogen bonding distance of the substrate analogue.
Steady-state kinetic analysis of Tyr299 and Arg307 site-directed mutants reveals that the ratio of the specificity
constant (kcat/Km) for allophanate compared to biuret decreases ∼200-fold for Y299F and that the R307A and
R307M mutants are nearly inactive. These results suggest a role for these residues in providing substrate and
intermediate stabilization in AH. Finally, the structure suggests the presence of an additional C-terminal domain
that is unique to AH and that may act as a functional linker between urea carboxylase and AH.

Materials and Methods
Materials
IPTG, NADH, and kanamycin were purchased from Research Products International Corp. (Mount Prospect, IL).
Ni2+-Profinity IMAC resin was obtained from Bio-Rad (Hercules, CA). Q-Sepharose ion-exchange resin was
obtained from Amersham Biosciences, GE Healthcare (Pittsburgh, PA). All other materials were obtained from
Sigma-Aldrich. Potassium allophanate was prepared by hydrolyzing ethyl allophanate (Acros Organics, Fisher
Scientific, Pittsburgh, PA) as described previously.(19)

Construction of an Expression Vector for His-Tagged Allophanate Hydrolase
Genomic DNA from G. bethesdensis (strain ATCC BAA-1260/CGDNIH1) was obtained from American Type Culture
Collection (Manassas, VA). The allophanate hydrolase gene (GenBank entry ABI62642.1) was amplified by
polymerase chain reaction (PCR) using the primers 5′-GAA GCT GCA GAT GAC GCT GAG CAT G-3′ and 5′-CAG ACT
CGA GCT TAC TGC GCC AAA TA-3′. Primers were synthesized by Integrated DNA Technologies (Coralville, IA). The
PCR-amplified fragment was digested with PstI and XhoI and ligated into the PstI- and XhoI-digested pET28a-

(His)8-TEV vector, downstream of the T7 promoter, N-terminal (His)8 tag, and rTEV protease recognition
sequence.(20) The Tyr299 and Arg307 single and double mutations were generated for this study by QuikChange
site-directed mutagenesis (Stratagene, La Jolla, CA) using Pfu Turbo polymerase. The complete sequence of all
cloned and mutagenized genes was verified by Functional Biosciences (Madison, WI).

Overexpression and Purification of Protein
Escherichia coli HMS174(DE3) cells were transformed with the pET28a-(His)8-TEV plasmid encoding wild-type or
mutagenized GbAH and were grown in LB medium containing 25 μg/mL kanamycin. LB medium (1 L) was
inoculated with a single colony transformant and incubated overnight at 37 °C. The overnight culture was used
to inoculate 12 L of LB medium that was grown at 37 °C to an OD600 of 0.8. The cultures were chilled in an
ice/water bath prior to induction with IPTG to a final concentration of 1 mM. The cultures were transferred to a
16 °C shaking incubator for 24 h prior to cell harvesting.
Both wild-type and mutant GbAH were purified using Ni2+-affinity and ion-exchange chromatography. The
harvested cells were disrupted by sonication in buffer containing 50 mM HEPES (pH 8.0), 300 mM NaCl, and 0.1
mM EGTA and centrifuged at 12000 rpm and 4 °C prior to being loaded onto a column containing 10 mL of Ni2+Profinity IMAC resin. The column was washed using buffer containing 20 mM imidazole, and the protein was
eluted from the column using a gradient from 20 to 300 mM imidazole, with GbAH eluting between 100 and 250
mM. The purified protein was subsequently pooled and dialyzed overnight at 4 °C against buffer containing 20
mM HEPES (pH 8.0), 50 mM NaCl, 1 mM EGTA, and 2 mM DTT prior to being loaded onto a 10 mL Q-Sepharose
ion-exchange column. The column was washed using buffer containing 50 mM NaCl, and the protein was eluted
using a gradient from 100 to 750 mM NaCl. The purified protein fractions were pooled, concentrated to 17
mg/mL, dialyzed overnight at 4 °C against storage buffer containing 10 mM HEPES (pH 8.0), 50 mM NaCl, and 1
mM DTT, and drop-frozen in liquid nitrogen for storage at −80 °C. The protein concentration was determined
spectrophotometrically using the calculated molar extinction coefficient for G. bethesdensis AH of 61810 M–
1
cm–1 at 280 nm.(21) Typical yields were ∼10 mg/L. The purity and subunit molecular mass were estimated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE). The purity was >99%, and the
molecular mass was determined to be ∼65 kDa. Analytical gel filtration chromatography was performed on a
Superose 6 HR 10/30 column (GE Healthcare) in buffer containing 20 mM HEPES (pH 7.5), 150 mM NaCl, and 1
mM DTT.

Protein Crystallization
Crystals of GbAH, both with and without malonate, were grown at room temperature by the hanging-drop vapor
diffusion method. Crystals of GbAH with malonate were obtained from a well solution of 100 mM PIPES (pH 6.5)
and 1.04 M sodium malonate. The crystals of apo GbAH were obtained from a well solution of 100 mM HEPES
(pH 7.5), 24% PEG 4K, and 50 mM MgCl2. In both cases, the protein solution (4 mg/mL) and reservoir solution
were mixed in a 1:1 ratio, yielding a final volume of 5 μL. The initial GbAH crystals grew spontaneously from a
well solution of 100 mM PIPES (pH 6.5) and 1.04 M sodium malonate after 2 months. Subsequently, all drops
were microseeded with pulverized GbAH crystals ∼24 h after mixing. The resulting diamond-shaped GbAH
crystals grew within 5–7 days of seeding. After 10–15 days, the crystals of GbAH with malonate were transferred
to a cryoprotectant solution consisting of 6 M sodium malonate and 100 mM PIPES (pH 6.5). The crystals of
apo GbAH were transferred to a cryoprotectant solution consisting of 100 mM HEPES (pH 7.5), 35% PEG 4K, and
50 mM MgCl2. All crystals were flash-cooled in a nitrogen gas stream at 100 K.
The crystals belonged to space group P61, with two subunits in the asymmetric unit and the following unit cell
parameters: a = 78 Å, b = 78 Å, c = 395 Å, α = β = 90°, and γ = 120°.

Data Collection, Structure Determination, and Refinement
X-ray diffraction data were collected at Sector 21 (LS-CAT) of the Advanced Photon Source (APS, Chicago, IL). The
diffraction data for GbAH with malonate were collected using beamline 21-ID-D with a MAR 300 CCD detector at
a wavelength of 1.033 Å. The diffraction data for apo GbAH were collected using beamline 21-ID-F with a MAR
225 CCD detector at a wavelength of 1.033 Å. Diffraction images were processed with HKL2000.(22) The
structure of GbAH with malonate was determined by molecular replacement using a putative amidase protein
[Protein Data Bank (PDB) entry 2DC0] as the search model using AutoMR(23) from the Phenix software suite.
The apo GbAH structure was determined by molecular replacement using GbAH with malonate as the search
model with AutoMR. The initial models were subsequently built with AutoBuild,(24) extended by several rounds
of manual model building with COOT,(25) and refined with Phenix.Refine.(26) Water molecules were added to
the model in COOT with subsequent manual verification. Data collection and processing statistics are
summarized in Table 1. The long unit cell axis of 395 Å resulted in some overlapping reflections. This was
particularly problematic for data collected on the MAR 225 CCD detector on LS-CAT-21-ID-F. Consequently, the
values for Rmerge and some refinement statistics are slightly elevated but still fall well within the acceptable
range.
Table 1. Data Collection and Refinement Statisticsa
PDB entry
space group
cell dimensions
a, b, c (Å)
α, β, γ (deg)
resolution range (Å)
redundancy
completeness (%)
Rmerge (%)
average I/σ
Rwork
Rfree
no. of reflections
no. of atoms
protein
others
water
Wilson B factor
average B factor (Å)
protein
ligand
solvent
Ramachandran (%)
favored
allowed
generous
disallowed
root-mean-square deviation
bond lengths (Å)

GbAH with sodium malonate apo GbAH
4GYS
4GYR
P61
P61
78, 78, 395
90, 90, 120
50–2.2 (2.26–2.20)
9.2 (6.6)
97.2 (96.2)
11.5 (33.2)
21.2 (4.9)
0.174 (0.218)
0.202 (0.275)
66210
7294
6840
28
426
31.5

78, 78, 398
90, 90, 120
50–2.8 (2.87–2.80)
9.0 (4.6)
99.9 (100)
11.4 (17.1)
20.8 (18.1)
0.256 (0.296)
0.307 (0.363)
33600
6930
6814
0
116
40.3

32.4
36.3
35.7

40.0
–
35.7

89.0
11.0
0
0

85.5
14.3
0.3
0

0.011

0.005

a

bond angles (deg)
1.28
Values in parentheses are for the highest-resolution bin.

0.91

Enzyme Assays
The activity of wild-type GbAH and Tyr299 mutants with allophanate was assayed using a glutamatedehydrogenase coupled assay at 340 nm(27) in 50 mM HEPES (pH 7.4), containing 50 mM NaCl and 1 mM EGTA
in the presence of 10 mM allophanate, 40 units of glutamate-dehydrogenase (GDH), 20 mM α-ketoglutarate,
and 0.5 mM NADH. The activity of GbAH with substrate analogues and the activity of the GbAH Arg307 mutant
with allophanate were assayed using a fixed-time phenol-hypochlorite assay in 50 mM HEPES (pH 7.4), 150 mM
NaCl, and 1 mM DTT.(28) A background rate was observed in all GDH-coupled reactions, but it was subtracted
from the AH-catalyzed rate. The reaction with substrate analogues was slow and in some cases was monitored
for up to 10 h to estimate rate constants. Despite the slow reaction rates, enzyme-catalyzed reactions (typically
1000 min–1) could easily be measured over the very slow background rate of spontaneous hydrolysis (∼20 min–
1
). One unit of enzyme is defined as the amount of enzyme required to hydrolyze 1 mol of substrate/min at 25
°C.
Enzyme kinetic constants were estimated by nonlinear curve fitting using GraphPad Prism version 3.02
(GraphPad Software Inc., San Diego, CA). The apparent Km and kcat values were determined by fitting to the
Michaelis–Menten equation for single-enzyme systems.

Results
Overall Structure of AH
Allophanate hydrolase (AH) was cloned from the genomic DNA of a phylogenetically diverse group of bacteria,
including G. bethesdensis, Pseudomonas syringae, Wolinella succinogenes, and Verminephrobacter eiseniae.
Only G. bethesdensis AH (GbAH) was amenable to crystallization. G. bethesdensis is an emerging opportunistic
pathogen, first isolated in 2006 from patients with chronic granulomatous disease.(29) The X-ray crystal
structure of GbAH with malonate was determined by molecular replacement using a putative amidase (PDB
entry 2DC0, sequence 32% identical to that of GbAH) as a search model and was refined to 2.2 Å resolution. The
apo GbAH structure was determined to 2.8 Å using GbAH with sodium malonate (4GYS) as a search model
(Table 1). A large number of overlapping reflections in the data set collected for the apo GbAH structure resulted
in acceptable but higher than optimal values for Rmerge, R, and Rfree. For this reason, descriptions of the apo GbAH
structure are limited to comparative analyses of global and active site structure, and the figures and conclusions
presented here are based entirely on the high-quality structure of GbAH with malonate.
In both the apo and ligand-bound structures, the GbAH crystal lattice is composed of a homodimer in the
asymmetric unit (Figure 1A). In malonate-bound GbAH, each subunit includes 461 residues (residues 3–463),
while in the apo GbAH structure, each subunit includes 462 residues (residues 2–463). In all cases, the subunits
consist of a globular amidase domain comprised of 15 α-helices and 11 β-strands, consistent with structures
from other AS family enzymes.(11) The N-terminal poly-His tag and C-terminal residues 463–592 were not
defined in the electron density of either the apo or malonate-bound structure and are not included in the
models. SDS–PAGE of isolated GbAH crystals grown in the presence of malonate demonstrated that the
complete 65 kDa protein was intact in the crystals (data not shown). Therefore, the undefined C-terminus
results from a lack of direct phasing information combined with intrinsic disorder in this region. Structural
alignments of GbAH with other AS family enzymes show conservation of the overall structure despite low
degrees of sequence similarity, ranging from 9 to 32% (Figure 1B–D). Analysis of the AH structure using the DALI
server(30) confirms that AH is homologous with several AS family member enzymes (Table S1 of the Supporting

Information). Glutamyl-tRNA amidotransferase subunit A (GatA) is the most closely related in structure, as
measured by both z score and root-mean-square deviation.

Figure 1. Structure of GbAH and structural comparison with other AS family enzymes. (A) Overall structure of
AH. The overall structure is shown as a cartoon. Malonate binding at the active sites is shown in CPK-colored
spheres. The three subdomains in each subunit are individually colored: blue for the N-terminal subdomain, hot
pink for the amidase signature sequence (Phe71–Leu182) subdomain, and yellow for the C-terminal subdomain.
The corresponding subdomains in the second subunit are colored light blue, light pink, and light yellow,
respectively. (B–D) Structural superimposition of the GbAH monomer (cyan) with other AS family enzymes. (B)
Alignment of AH and Staphylococcus aureus GatA (PDB entry 2F2A, salmon). (C) Alignment of AH
and Bradyrhizobium japonicum malonamidase (MAE2, PDB entry 1OCL) subunit A (white). (D) Alignment of AH
and rat fatty acid amide hydrolase (FAAH, PDB entry 1MT5) subunit A (magenta). (E and F) Structural
superimposition of the GbAH dimer (cyan) with other AS family enzyme dimers: (E) MAE2 (white) and (F) FAAH
(magenta).
Analytical gel filtration analysis of GbAH revealed a holoenzyme with a molecular mass of ∼130 kDa, while SDS–
PAGE revealed an ∼65 kDa monomer (data not shown), confirming that the biological unit is a dimer, consistent
with characterization of other AH enzymes.(15, 17) The dimerization interface was analyzed using the PDBe PISA
server.(31) Three dimerization interfaces were identified as having a large buried surface area and favorable
ΔG (Figure S1A of the Supporting Information). The biological dimer was determined to be that with the largest
buried surface area and the most favorable ΔG (Figure S1B of the Supporting Information). Of the three possible
interfaces, this dimerization interface is most similar, though not identical, to the dimerization interface of the
AS family enzymes fatty acid amide hydrolase and malonamidase (Figure 1E,F and Supplementary Figure S1B of
the Supporting Information).

GbAH Active Site Architecture
AH shares a common catalytic mechanism with other AS family members, using a conserved Ser-cis-Ser-Lys triad
to catalyze amidolysis of allophanate.(17, 32) As in other AS family members, three conserved residues,
Ser172, cis-Ser148, and Lys74, form the expected catalytic triad in GbAH with an oxyanion hole formed by the
backbone amide nitrogens of Asp168, Thr169, Ala170, and Gly171. When GbAH was crystallized in sodium malonate
(1.04 M), one molecule of malonate was bound at the active site and a second molecule was bound at the
protein surface. In crystals grown in the absence of malonate, no electron density corresponding to a bound

ligand was observed. The binding of malonate in the active site did not result in any structural rearrangements
compared with the ligand-free enzyme (Figure 2A,B). On the basis of the proposed mechanism of homologous
AS family enzymes and analysis of inactivated and mutated AH enzymes, Ser172 acts as the catalytic nucleophile
to attack the amide carbon on allophanate while Ser148 acts as a general acid catalyst to stabilize the enzyme–
substrate intermediate.(11, 17, 32) The deprotonated form of Ser148 is maintained by Lys74 through a hydrogen
bond, and the tetrahedral intermediate is stabilized by the oxyanion hole. The catalytic triad facilitates the
subsequent hydrolysis of the terminal amide bond to yield a Ser172-dicarboxylated amide and one molecule of
NH3. It is not clear whether the dicarboxylated amide further decomposes while it is tethered to Ser172 or is
hydrolyzed intact from the enzyme and subsequently decomposes in solution.(32) The nucleophilic Ser172 points
away from malonate in the bound structure but is oriented toward the active site cavity in the ligand-free
enzyme (Figure 2B,C).

Figure 2. Structural superposition of apo GbAH with the malonate-bound structure. (A) Superimposition of
the GbAH monomer with (cyan) and without (purple) bound malonate reveals no significant conformational
changes accompanying substrate binding. The active site-bound malonate is shown as CPK-colored spheres. (B)
Stereoview showing the structural superimposition of the active sites of apo GbAH (purple) and malonatebound GbAH (cyan). A simulated annealing omit map for malonate, contoured at 3.0σ, is colored green. The
2Fo – Fc map, contoured at 1.0σ, is colored gray. For the sake of clarity, only side chains are displayed for Tyr299,
Arg307, Ser148, Ser172, and Lys74. Only main chain atoms are displayed for the oxyanion hole. (C) Stereoview
showing the active site of malonate-bound GbAH (cyan). The distances (in angstroms) are indicated. The
nucleophilic Ser172 adopts a conformation that is oriented away from malonate in the malonate-bound GbAH
structure. However, this residue can also adopt an orientation that is oriented toward the substrate’s

electrophilic center, as observed in the overlaid side chain of Ser172 from the apo GbAH structure (transparent
purple). (D) Sequence alignment of AH, UAL, and other AS family enzymes shows conservation of Tyr299 and
Arg307 among AH enzymes: GbAH (G. bethesdensis allophanate hydrolase), VeAH (V. eiseniae allophanate
hydrolase), PsAH (P. syringae allophanate hydrolase), ScUAL (Saccharomyces cerevisiae urea amidolyase), CaUAL
(C. albicans urea amidolyase), GatA [Thermotoga maritima glutamyl-tRNA(Gln) amidotransferase subunit A],
MAE2 (B. japonicum malonamidase E2), and FAAH (rat fatty acid amide hydrolase).
The crystal structures of GbAH with bound malonate also reveal two residues, Tyr299 and Arg307, within
interacting distance (2.6 and 2.8 Å, respectively) of one of the malonate carboxylate moieties (Figure 2C).
Sequence alignments reveal that both Tyr299 and Arg307 are conserved in all AH enzymes but that they are not
conserved across the AS family (Figure 2D). This suggests a role for these residues in facilitating substrate
binding in the enzyme active site.
The size of the active site cavity is relatively small compared to that of cavities of other AS family enzymes.
Measurement of the active site cavity using VOIDOO(33) reveals that the size of the cavity is closest to that of
GatA, which uses glutamine or asparagine as a substrate. The cavity size comparison shows a pronounced
difference between AH and malonamidase, an AS family enzyme that hydrolyzes a very similar substrate,
malonamate.

GbAH Enzyme Activity
The kcat for wild-type GbAH is 18.2 s–1; the Km is 0.10 mM, and the kcat/Km is 1.8 × 105 s–1 M–1 (Table 2). This falls in
a range of kcat/Km values previously determined for AH from Oleomonas sagaranensis (2.7 × 106 s–1 M–1),(15) AtzF
from Pseudomonas sp. strain ADP (1.1 × 104 s–1 M–1),(17) and TrzF from Enterobacter cloacae strain 99 (8.8 ×
103 s–1 M–1).(32)
Table 2. Kinetic Data of Wild-Type GbAH and Its Site-Directed Mutants with Allophanate
kcat (s–1)a
Km (mM)a
kcat/Kmb(s–1 M–1)
wild type
18 ± 1
0.10 ± 0.002 (1.8 ± 0.03) × 105
C_del
20 ± 1
0.30 ± 0.004 (6.9 ± 0.2) × 104
Y299F
(4.2 ± 0.1) × 10–2 1.2 ± 0.1
35 ± 3
Y299A
(7.1 ± 0.2) × 10–2 3.0 ± 0.4
24 ± 3
R307A
–
–
(1.7 ± 0.2) × 10–3
R307M
–
–
(3.6 ± 0.8) × 10–3
Y299A/R307M –
–
(1.9 ± 0.1) × 10–2
Y299F/R307M –
–
(7.1 ± 0.6) × 10–3
Y299A/R307A –
–
(2.7 ± 0.2) × 10–2
a
Mean ± standard deviation (n = 3).
b
kcat/Km estimated from the slope of vi vs [S] at [S] ≪ Km; mean ± standard deviation (n = 3).

Substrate Specificity
AH has been shown to exhibit high specificity for allophanate.(15, 32) To assess the substrate specificity
of GbAH, the rate of ammonia release was measured for a series of allophanate analogues, including biuret,
malonamide, acetyl-urea, hydantoic acid, l-glutamine, and l-asparagine (Figure S2 of the Supporting
Information). Among this group of substrate analogues, activity was only detected with biuret and malonamide,
consistent with previous reports.(32) The measured kinetic constants for GbAH with allophanate and the
substrate analogues biuret and malonamide are listed in Table 3 with representative data provided in Figure S3
of the Supporting Information.

Table 3. Kinetic Data for Wild-Type GbAH and Its Mutants with Substrate Analogues
biuret kcat/Km [kcat/Km(biuret)]/[kcat/Km(allo ratio to wild malonamide kcat/Kma(
a(s–1 M–1)
phanate)]
type
s–1 M–1)
–6
wild type
0.30 ± 0.01
(1.7 ± 0.1) × 10
1
0.38 ± 0.01
–6
C_del
0.59 ± 0.02
(8.6 ± 0.4) × 10
5.2
0.35 ± 0.01
Y299F
0.35 ± 0.02
(1.0 ± 0.1) × 10–2
6.1 × 103
0.12 ± 0.01
–2
4
Y299A
1.0 ± 0.02
(4.3 ± 0.6) × 10
2.6 × 10
0.36 ± 0.02
a
kcat/Km estimated from the slope of vi vs [S] at [S] ≪ Km; mean ± standard deviation (n = 3).

[kcat/Km(malonamide)]/[kcat/Km(
allophanate)]
(2.1 ± 0.2) × 10–6
(5.1 ± 0.2) × 10–6
(3.5 ± 0.1) × 10–3
(1.5 ± 0.2) × 10–2

ratio to
wt
1
2.4
1.6 × 103
7.2 × 103

Tyr299 and Arg307 are within hydrogen bonding distance (2.6 and 2.8 Å, respectively) of one carboxylate moiety of
malonate (Figure 2C). Both Tyr299 and Arg307 were mutated in GbAH to investigate the role of these two residues
in catalysis. A series of single mutants (Y299F, Y299A, R307M, and R307A) and double mutants (Y299A/R307M,
Y299F/R307M, Y299A/R307A, and Y299F/R307A) were assayed for catalytic activity. While the dimerization
interface is located in the proximity of the active sites, analytical gel filtration confirmed that mutations in the
active site residues located near the interface (i.e., Ser172, Tyr299, and Arg307) did not alter the oligomerization
state of the enzyme (Figure S4 of the Supporting Information). The kinetic constants measured with allophanate
revealed ∼400- and ∼250-fold reductions in kcat for Y299F and Y299A, respectively, and ∼5000- and ∼7500-fold
reductions in kcat/Km for Y299F and Y299A, respectively (Table 2). In addition, mutations of Tyr299 altered the
enzyme’s discrimination between substrates, increasing the specificity constants for biuret and malonamide
relative to that for allophanate. The kcat/Km ratio for biuret compared to that for allophanate increased by 3
orders of magnitude in Y299F and 4 orders of magnitude in Y299A (Table 3). By comparison, mutations of
Arg307 had a much more dramatic effect on the rate of catalysis. The kcat/Km is estimated to be 2–4 × 10–3 s–1 M–
1
for Arg307 mutants, resulting in a decrease in kcat/Km of 8 orders of magnitude. No activity could be observed for
Arg307 mutants with biuret or malonamide.

Function of the C-Terminal Domain
While the structures in the presence and absence of malonate defined the 462-amino acid globular amidase
domain, the 126 C-terminal amino acids were disordered in both structures. This suggests that an additional,
less structured domain of unknown function resides at the C-terminus of AH. This domain is conserved in all AH
enzymes but is missing in other AS family enzymes (Figure 3). To determine whether the C-terminal domain
influences the overall amidase activity, the 126 C-terminal amino acids were truncated by introducing two stop
codons immediately following the codon encoding the last ordered residue from the crystal structure, Thr462.
The C-terminally truncated enzyme was overexpressed and purified, and the molecular mass was confirmed to
be ∼50 kDa by SDS–PAGE, compared to the full-length ∼65 kDa wild-type enzyme. The truncated enzyme
maintained its ability to dimerize, as measured by analytical gel filtration (Figure S4 of the Supporting
Information). Furthermore, truncation of the C-terminus had very little effect on the kinetic constants.
The kcat and Km values measured for the C-terminal truncation were very similar to those measured for the wildtype enzyme, both with the substrate and with substrate analogues (Tables 2 and 3), indicating that the Cterminal domain does not significantly influence amidase activity or substrate specificity.

Figure 3. C-Terminal domain of GbAH. (A) Structure of the amidase domain of AH with a cartoon representation
showing the missing C-terminal domain, depicted as green ovals encircled by a dotted line. (B) Schematic
representation of the domain arrangement of AH, urea carboxylase, urea amidolyase, and other AS family
enzymes.

Discussion
Acylamide amidohydrolase enzymes (EC classification group 3.5.1) catalyze the hydrolysis of linear amide bonds
in a wide range of substrates. Several enzyme superfamilies with unrelated sequence and structure have
converged on this common enzymatic function, including the amidohydrolase, nitrilase, and amidase signature
(AS) superfamilies. Members of the AS superfamily catalyze amidolysis without the assistance of a metal ion,
instead using a nucleophilic serine and oxyanion hole to mediate the formation and stabilization of the
tetrahedral transition state. The superfamily was originally identified and characterized by a signature block of
130 amino acids rich in conserved Gly and Ser residues.(2) Subsequent structural and kinetic studies of AS family
enzymes revealed a conserved Ser-cis-Ser-Lys catalytic triad that is essential for catalysis.(11, 34-36) The
structures of a few well-characterized members of the AS family have been reported in recent years, including
those of GatA,(37) malonamidase,(11) fatty acid amide hydrolase,(38) and peptide amidase.(39) These
structures have confirmed a common catalytic core and have revealed a diverse active site architecture that
accommodates both stringent and promiscuous activities over a wide range of substrates.
AH is a typical AS family enzyme using a Ser-cis-Ser-Lys catalytic triad to hydrolyze allophanate to ammonia and
carbon dioxide. In some bacterial strains, AH works in conjunction with cyanuric acid amidohyrolase (EC
3.5.2.15) and biuret amidohydrolase (EC 3.5.1.84) to catalyze the final steps of s-triazide degradation.(17, 32,
40) In certain fungi and prokaryotes, AH functions in concert with urea carboxylase to degrade urea.(16,
41) Prior to this investigation, no structure of AH had been reported. Several studies have described a high
degree of substrate specificity in AH,(15, 17, 32) but in the absence of structural insights, the molecular basis for
this specificity has not been defined.

General Features of the AH Structure
Both the overall fold and the position of the catalytic triad in GbAH superimpose well with those of other
members of the AS family. However, comparison of the AH dimer with homologous structures reveals that the
superfamily exhibits a surprising plasticity at the dimerization interface. A structural alignment of GbAH with
dimeric superfamily members shows that the dimerization interface varies between enzymes, leading to a wide
variation in the distance between active sites, ranging from 33 to 60 Å (Figure 1E,F). The absence of a conserved
dimerization interface in the AS family suggests that dimerization does not play an essential role in catalysis and
that the individual active sites most likely function independently. Indeed, some AS family members do not form
homodimers: GatA, the glutamine amidohydrolase component of GatCAB, makes up a heterotrimer with GatB
and GatC subunits,(5) and in vivo and in vitro studies of Arabidopsis amidase-1 have concluded that there is no
interaction between the amidase monomers.(42) Nevertheless, the relationship between dimerization and
catalytic activity in AH warrants further investigation considering that the essential active site residues Tyr299 and
Arg307 (vide infra) are positioned near the dimerization interface. A connection between dimerization and
substrate specificity has been proposed for the AS family nitrile amidase from Rhodococcus sp. N-771, in which a
modified dimerization interface reduces the width of the substrate binding tunnel, thereby limiting the access of
larger substrates.(6)
Comparison of the ligand-free and malonate-bound structures of GbAH reveals no structural rearrangements
accompanying ligand binding in the active site (Figure 2B), consistent with other AS family enzymes.(8, 11) Thus,
from X-ray structures, it appears that the active sites of AS enzymes are rigid assemblies and that substrate

discrimination arises by limiting substrate access to the active site and by the design of specific architectures
that are complementary to the substrate(s). This apparent rigidity of AS active sites makes the superfamily
particularly amenable to functional predictions by in silico ligand docking, as described in a recent review.(43)

Substrate Specificity Determinants in AH
Previous studies of AH cloned from E. cloacae (TrzF) and Pseudomonas sp. strain ADP (AtzF) confirmed the
identity of the Ser-cis-Ser-Lys catalytic triad and documented a detectable promiscuous activity with the
alternate substrates biuret, malonamide, and malonamate.(17, 32) TrzF has a specific activity of 0.5 nmol min–
1
mg–1 with biuret and 1.5 nmol min–1 mg–1 with malonamide.(32)GbAH has a similar activity of 8.3 nmol min–
1
mg–1 with biuret and 2.3 nmol min–1 mg–1 with malonamide. Conversely, AH from Oleomonas sagaranensis had
no detectable activity with biuret or malonamide.(15) Whereas the identity of the catalytic triad and the low
tolerance for analogous substrates have been documented in AH, the active site residues contributing to
substrate recognition have not been described because of a lack of structural information. In this study, the
structure of the GbAH–malonate complex combined with kinetic analysis of GbAH modified by site-directed
mutagenesis has revealed an important role for two conserved residues, Tyr299 and Arg307. The side chains for
these amino acids are positioned 2.6–2.8 Å from the carboxylate moiety of the substrate analogue, malonate
(Figure 2C). Mutations of Arg307 result in a nearly complete loss of catalytic activity, while mutations of
Tyr299 substantially decrease kcat and kcat/Km for allophanate and reduce the substrate preference of AH for
allophanate compared with those for biuret and malonamide (Tables 2 and 3).
While malonate is not an ideal isosteric mimic of allophanate, the GbAH structure with bound malonate can be
combined with kinetic analysis of GbAH site-directed mutations to propose a role for Tyr299 and Arg307 in AH
catalysis. The side chain of Tyr299 is 2.6 Å from the carboxylate oxygen of malonate. This residue is proposed to
donate a hydrogen bond to the deprotonated carboxylate of allophanate. The donation of a hydrogen bond
from Tyr299 would facilitate discrimination between the carboxylate moiety of the bona fide substrate,
allophanate, and the amide substituent of the substrate analogues, biuret and malonamide. The reduced level
of discrimination between allophanate and malonamide/biuret in Tyr299 mutations is consistent with this
proposal. In addition, the side chain of Arg307 is 2.8 Å from the other carboxylate oxygen of malonate, suggesting
that Arg307 interacts with the substrate carboxylate via a salt bridge in a manner analogous to interactions with
substrate carboxylate moieties in malonamidase and GatA (vide infra). The nearly complete loss of catalytic
activity with allophanate observed in site-directed mutations at Arg307 is consistent with this proposal. The
formation of a salt bridge between Arg307 and the substrate would serve to bind and orient the substrate in the
proximity of the catalytic triad and also to assist in stabilizing developing negative charge in the transition state.
The inability of wild-type AH to form a salt bridge with the alternate substrates biuret and malonamide may
further account for the poor reactivity of these substrates. Substrate discrimination in AH, therefore, may
originate from anchoring the carboxylate moiety of allophanate in the active site opposite the catalytic triad
and, thus, properly positioning and orienting the amide portion of the substrate for nucleophilic attack. It is
conceivable that substrate analogues such as biuret, malonamide, and asparagine are anchored improperly and,
consequently, the terminal amide of these substrates is improperly positioned for attack by the
Ser172 nucleophile of the catalytic triad. Confirmation of this proposal awaits structures of GbAH bound with
alternate substrates.
Malonamate is a structural analogue of allophanate and the substrate of the AS family enzyme, malonamidase.
Given the similarity between the substrates, these two enzymes might be expected to share similar active site
architectures. However, structural and phylogenetic analysis(17) reveals that malonamidase and AH are
distantly related AS superfamily members. Instead, AH is most closely related to GatA, bacterial glutamyl-tRNA
amidotransferase subunit A. Interestingly, all three of these enzymes position an Arg side chain for salt bridge
formation with the substrate carboxylate moiety while AS family enzymes acting on non-carboxylated substrates

do not (Figure 4). In malonamidase, this residue (Arg158) is located on the opposite side of the active site
compared with its location in AH and GatA, resulting in a completely different substrate binding orientation
(Figure 3A). This arginine is replaced by a valine in AH and a glutamine in GatA. In addition, an active site loop
(amino acids 119–125 in GbAH) present in most AS family enzymes adopts a variety of conformations and
contributes to substrate specificity by dictating the orientation of the substrate in the active site. In
malonamidase, this loop adopts an atypical conformation, forcing the substrate into a different binding
orientation (Figure 4A and Figure S5 of the Supporting Information).

Figure 4. Comparison of substrate binding residues at the active sites of GbAH with other AS family enzymes. (A)
Alignment of malonate-bound GbAH (cyan) and malonate-bound B. japonicum malonamidase (PDB entry 1OCL,
white). (B) Alignment of malonate-bound GbAH (cyan) and S. aureus GatA with covalently bound glutamine (PDB
entry 2F2A, salmon). (C) Alignment of malonate-bound GbAH (cyan) and benzamide-bound Rhodococcus sp. N771 amidase (PDB entry 3A1I, yellow). (D) Alignment of malonate-bound GbAH (cyan) with rat fatty acid amide
hydrolase (PDB entry 1MT5, pink) with the bound inactivator methoxy arachidonyl fluorophosphonate (MAY).
Residues and substrates are shown as sticks, labeled and colored according to their structure.
The substrate binding orientation and the position and identity of the side chains responsible for substrate
binding are very similar between GatA and AH (Figure 4B). In the GatA structure, an alanine replaces
Arg307 of GbAH. However, GatA positions a different arginine side chain at a similar location in the active site,
allowing the guanidinium side chain to form a salt bridge with the substrate carboxylate. This guanidinium group
is 7 Å further removed from the catalytic triad in GatA than in GbAH, allowing the longer substrates, asparagine
and glutamine, to be properly positioned in the triad of GatA. It is notable that AH does not catalyze the
hydrolysis of either glutamine or asparagine. The difference in the arginine side chain position may explain this
discrimination, accounting for the specificity of GatA for longer substrates and AH for shorter substrates. In the
heterotrimeric GatCAB complex, an ammonia channel runs from the GatA glutaminase active site to the
transamidase catalytic pocket in GatB.(5, 37) This same channel appears to be present in GbAH and may serve as
an exit channel for the release of the ammonia (Figure S6 of the Supporting Information).

A Structurally Independent C-Terminal Domain in AH
The structures of GbAH reveal the presence of a unique C-terminal domain that is not present in other AS family
enzymes but is conserved in AH and urea amidolyase. Deletion of this domain did not significantly influence the
dimerization or catalytic activity of GbAH. The functional role of this domain, therefore, cannot yet be
unambiguously assigned. However, given that AH activity is typically coupled to the reaction of urea carboxylase
and that they comprise separate domains of urea amidolyase in yeast (Figure 3B), it is tempting to speculate

that the C-terminal domain of AH facilitates the interaction and coupling between AH and urea carboxylase
enzymes or between the individual catalytic domains in urea amidolyase. In the heterotrimeric GatCAB, a small
GatC subunit links GatA and GatB and is essential for maintaining GatCAB structure and activity.(37, 44, 45) In
bacteria, the genes encoding urea carboxylase and AH are tightly clustered, suggesting that they may coordinate
their activities.(16) However, studies examining the interaction between urea carboxylase and AH indicate that
AH and urea carboxylase do not form a stable complex,(15) consistent with studies of AH and urea carboxylase
from P. syringae (Figure S7 of the Supporting Information). The absence of a stable complex between AH and
urea carboxylase does not, however, preclude the possibility of a transient interaction between the two
enzymes that may serve to facilitate the efficient transfer of intermediates.(46, 47) Furthermore, additional
proteins may be required to maintain a stable complex between AH and urea carboxylase. It is notable that two
additional putative cytoplasmic proteins of unknown function (GenBank
entries YP_745567 and YP_745568 in G.bethesdensis) are located in the proximity of the genes for AH and urea
carboxylase in many bacteria. Structural and kinetic studies are currently underway to clarify whether additional
proteins mediate multienzyme complex formation via the C-terminal domain of AH and to determine the extent
of substrate channeling that exists between urea carboxylase and AH.
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Abbreviations
AH
APS
AS
DTT

allophanate hydrolase
Advanced Photon Source
amidase signature
dithiothreitol

EGTA
GatA
GatCAB
GbAH
GDH
Gln-tRNAGln
HEPES
IPTG
NADH
TEV
PEG
PIPES
SDS–PAGE

ethylene glycol bis(2-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
glutamyl-tRNA amidotransferase subunit A
heterotrimeric glutamyl-tRNA amidotransferase CAB
G. bethesdensis allophanate hydrolase
glutamate-dehydrogenase
glutaminyl-tRNAGln
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
isopropyl β-d-1-thiogalactopyranoside
reduced nicotinamide adenine dinucleotide
tobacco etch virus
poly(ethylene glycol)
piperazine-N,N′-bis(2-ethanesulfonic acid)
sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
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